Navigation Links
University of Wisconsin Carbone Cancer Center to Acquire ViewRay Radiation Therapy System
Date:3/9/2011

CLEVELAND, March 9, 2011 /PRNewswire/ -- The University of Wisconsin Carbone Cancer Center (UWCCC) in Madison, Wisconsin, will soon become one of the first oncology research centers to acquire a radiotherapy system from ViewRay™, Inc., a privately held medical device company. ViewRay's new research radiation therapy system features a unique combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI). The ViewRay system is being designed to provide continuous soft-tissue MRI during treatment so that clinicians can see precisely where the radiation is being delivered.

Radiation therapy is critical in the fight against cancer, and nearly two-thirds of all cancer patients receive radiation therapy during their illness. However, natural organ motion can hinder the precision of radiation delivery to the tumor. "Patients breathe, swallow, and digest with movement of internal organs during treatment," said Paul M. Harari, MD, professor and chair of the UW Department of Human Oncology. "We plan to use the system to observe and address this problem in a new way with the use of MR imaging. Our researchers are particularly interested in studying possible applications in the treatment of thoracic, abdominal, and pelvic malignancies, where precise radiation targeting must account for organ motion."

The UWCCC is known for conducting some of the most innovative research in the field. A number of original treatment technologies have been developed at UW, particularly in the area of image-guided radiotherapy using pretreatment CT. "We have great respect for the work of UW's researchers and clinicians, and we've enjoyed a longstanding connection to the Carbone Cancer Center," said ViewRay President and CEO Gregory M. Ayers, MD, PhD. "Now the UWCCC team will lead the radiation oncology community in exploring a new way of monitoring treatments and adapting to changes in a patient's anatomy." The ViewRay system is designed to enable clinicians to plan and deliver precision radiotherapy and radiosurgery to treat lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated.

ViewRay holds the exclusive worldwide license for its combination of MRI and radiotherapy technologies. Now in the late stages of development, the ViewRay system is currently available only as a non–human use research system. The company is working to secure clearance from the U.S. FDA for commercial distribution of the system for clinical use.

About ViewRay

ViewRay, Inc., of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. Using MRI-guided radiotherapy, the ViewRay system is being designed to provide continuous soft-tissue imaging during treatment so that clinicians will be able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. The system is intended to give clinicians a fresh approach to observing, assessing, and personalizing a patient's treatment. For more information, visit http://www.viewray.com.

ViewRay acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Radiotherapy Guidance Project.

About the UW Carbone Cancer Center

The University of Wisconsin Carbone Cancer Center (UWCCC) is recognized throughout the nation as one of the leading innovators in cancer research, quality patient care, teaching, and active community involvement. An integral part of the UW School of Medicine and Public Health, the UWCCC unites more than 250 physicians and scientists who work together in translating discoveries from research laboratories into new treatments that benefit cancer patients. It is the only comprehensive cancer center, as designated by the National Cancer Institute, in the state of Wisconsin. For more information, visit http://www.uwhealth.org/.

ViewRay is a trademark of ViewRay, Inc.


'/>"/>
SOURCE ViewRay, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The University of Kansas Cancer Center and U.S. Oncology-Affiliated Kansas City Cancer Center to Merge Operations to Promote Patient Care and Research
2. Mira Dx Licenses Triple Negative Breast Cancer Risk Variant from Yale University
3. University Radiology Group Works With MedInformatix to Meet Stage 1 Meaningful Use Qualifications
4. Zell Lurie Institute Awards $106,300 to University of Michigan Students Through the Michigan Business Challenge and Dare to Dream Startup Grant Program
5. University of North Carolina Hospitals Selects Carefx Business Intelligence Dashboards To Drive Performance Improvement
6. University Hospitals Selects Allscripts Electronic Health Record for 1,400 Physicians and Expands Sunrise™ Enterprise Acute Care EHR in Eight Hospitals
7. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
8. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
9. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
10. Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGR® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
11. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Research and Markets has announced the addition of ... report to their offering. ... Traditional medical devices include devices (e.g., ... implantables, large endoscopes, needle based drug delivery, lab based diagnostics ... to three decades for the treatment and management of various ...
(Date:2/16/2017)... -- DaVita Inc. (NYSE: DVA ) today announced ... Net income attributable to DaVita Inc. for ... million, or $0.80 per share and $880 million, or $4.29 ... to DaVita Inc. for the quarter and year ended December ... million, or $0.98 per share, and $789 million, or $3.85 ...
(Date:2/16/2017)... 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... today announced that executive management will participate in the ... February 22-23, 2017. Adrian Adams , Chief Executive ... 1:35 p.m. local time on Wednesday, February 22, 2017. ... the event may be accessed from the Investors section ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... ... Braun Industries will be participating as an exhibitor at EMS Today 2017. ... 23-25, 2017 at the Calvin L. Rampton Salt Palace Convention Center in Salt Lake ... on display. , “JEMS is a leader in EMS news and education. ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... in better care, and MEDfx and the Delaware Health Information Network (DHIN) have ... As the nation’s first state-wide health information exchange, DHIN stores and shares real-time ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... Axendia, **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. – 2:30 ... regulatory burden? Pay dividends in enhanced and predictable product performance? Streamline processes ...
(Date:2/18/2017)... ... 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its manufacturing ... Ken was impressed with the safety and reliability of the Stannah Stairlift as ... show. This endorsement by Ken Matthews can be heard on News Radio WHP ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter ... Show on the Pet Life Radio network. The episode, which was posted this ... topics including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 ...
Breaking Medicine News(10 mins):